McKesson (NYSE: MCK) reported earnings on Jan. 31. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q3), McKesson beat slightly on revenues and whiffed on earnings per share.

Compared to the prior-year quarter, revenue grew slightly and GAAP earnings per share increased.

Gross margins grew, operating margins dropped, net margins were steady.

Revenue details
McKesson reported revenue of $31.19 billion. The 12 analysts polled by S&P Capital IQ predicted sales of $30.85 billion on the same basis. GAAP reported sales were 1.1% higher than the prior-year quarter's $30.84 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $1.41. The 14 earnings estimates compiled by S&P Capital IQ anticipated $1.62 per share. GAAP EPS of $1.24 for Q3 were 3.3% higher than the prior-year quarter's $1.20 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 5.3%, 10 basis points better than the prior-year quarter. Operating margin was 1.6%, 20 basis points worse than the prior-year quarter. Net margin was 1.0%, about the same as the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $31.66 billion. On the bottom line, the average EPS estimate is $2.20.

Next year's average estimate for revenue is $122.99 billion. The average EPS estimate is $7.27.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 599 members out of 626 rating the stock outperform, and 27 members rating it underperform. Among 220 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 212 give McKesson a green thumbs-up, and eight give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on McKesson is outperform, with an average price target of $104.23.

Is McKesson the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.

Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool recommends McKesson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.